In this episode, Dr. Schim joins us to discuss Trudhesa, a newly approved abortive migraine treatment option. He explains the technology behind this new administration method for Dihydroergotamine nasal spray as well as efficacy and safety data. *This podcast is intended for general purposes only and does not constitute professional medical advice. AMD and the speaker do not endorse any treatment, products, procedures, opinions mentioned. Reliance on any information is at your own risk.